Dual antiplatelet therapy in acute transient ischemic attack and minor stroke

New England Journal of Medicine

Volumn 369, Issue 1, 2013, Pages 82-83

  Hankey, Graeme J ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; PRASUGREL; RIVAROXABAN; TICAGRELOR;

ACUTE CORONARY SYNDROME; ATHEROSCLEROTIC PLAQUE; BLEEDING; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; EDITORIAL; GENETIC POLYMORPHISM; HIGH RISK PATIENT; HUMAN; LOADING DRUG DOSE; LONG TERM CARE; PRIORITY JOURNAL; RECURRENCE RISK; RISK BENEFIT ANALYSIS; RISK REDUCTION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION;

EID: 84879739755     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1305127     Document Type: Editorial

References (13)

1. Merwick A, Albers GW, Amarenco P, et al. Addition of brain and carotid imaging to the ABCD 2 score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol 2010;9:1060-9.
2. Lovett JK, Coull A, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004;62:569-73. (Pubitemid 38252797)
3. Sandercock PAG, Counsell C, Gubitz GJ, Tseng MC. Antiplatelet therapy for acute ischemic stroke. Cochrane Database Syst Rev 2008;3:CD000029.
4. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502. [Errata, N Engl J Med 2001;345:1506, 1716.]
5. Geeganage CM, Diener HC, Algra A, et al. Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials. Stroke 2012;43:1058-66.
6. Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013;369:11-19.
7. Bhatt DL, Fox KAA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.
8. The SPS3 Investigators. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012;367:817-25.
9. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331-7.
10. ClinicalTrials.gov. Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial (http://clinicaltrials.gov/ct2/show/NCT00991029).
11. Idem. Triple Antiplatelets for Reducing Dependency After Ischemic Stroke (TARDIS) (http://clinicaltrials.gov/show/NCT01661322).
12. Aradi D, Komócsi A, Vorobcsuk A, Serebruany VL. Impact of clopidogrel and potent P2Y 12-inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and metaanalysis. Thromb Haemost 2013;109:93-101.
13. Mega JL, Braunwald E, Wiviott SD, et al. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 2012;366:9-19.